U wouldn’t find too many stocks let alone bio stocks do any good the past year but agree, we need some sort of deal otherwise the sp WILL matter when we r trying to raise money at such low levels. I think investors r far from convinced that this works as well as so many on here suggest. They r waiting for a deal or approval to validate it imo. If a phase 3 drug had outstanding results announced I don’t believe we would be sitting where we are even with the market the way it is imo.
Chart, page-3836
-
- There are more pages in this discussion • 467 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
19.0¢ |
Change
-0.010(5.00%) |
Mkt cap ! $66.54M | |||
| Open | High | Low | Value | Volume |
| 20.0¢ | 21.0¢ | 19.0¢ | $203.4K | 1.019M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 14 | 387930 | 19.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 20.5¢ | 65468 | 2 |
View Market Depth
| Last trade - 16.10pm 27/09/2024 (20 minute delay) ? |
| PAR (ASX) Chart |